Target intelligence / Profile preview

Novel transcript, antisense to DGKD (ENSG00000259793)

Target
ENSG00000259793
Molecular classification
Other (long non-coding RNA, lncRNA)
01

Overview

ENSG00000259793 encodes a long non-coding RNA (lncRNA), annotated as a "novel transcript, antisense to DGKD." This transcript is classified as lncRNA, which means it does not encode a protein and its biological function, if any, is undefined in the current scientific literature. There is no evidence that it is involved in canonical receptor, enzyme, transporter, or therapeutic target activity, nor is it associated with drug interactions or well-characterized disease roles. The annotation "antisense to DGKD" suggests it is transcribed from the opposite DNA strand adjacent to or overlapping the DGKD gene, but no functional characterization has been published. Clarification: - This is not a canonical therapeutic target (e.g., receptor, enzyme, or other druggable protein) and should not be considered one for purposes such as drug discovery or pharmacological profiling. - Its identification as an "antisense transcript" means it is best classified under "Other" in molecular class, specifically as a long non-coding RNA. - The record is likely to be incorrect as a drug target, given its lack of known biological function, druggability, or therapeutic relevance. If your intent was the protein-coding gene DGKD (Diacylglycerol kinase delta), see entries for ENSG00000077044, which is a kinase with established physiological and disease roles.

Other names
Novel transcript antisense to DGKDENSG00000259793

Beyond the preview

Go deeper on Novel transcript, antisense to DGKD (ENSG00000259793).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, antisense to DGKD (ENSG00000259793).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call